Circulating natural killer cells in retired asbestos cement workers

Journal of Occupational and Environmental Medicine

Volumn 42, Issue 1, 2000, Pages 19-24

  Froom, Paul ^a   Lahat, Nitza ^b   Kristal Boneh, Estela ^a   Cohen, Chaim ^a   Lerman, Yehuda ^a   Ribak, Joseph ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b CARMEL MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS;

ADULT; ARTICLE; ASBESTOSIS; CIGARETTE SMOKING; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG CANCER; LUNG DISEASE; LUNG FUNCTION; MAJOR CLINICAL STUDY; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL LUNG DISEASE; T LYMPHOCYTE SUBPOPULATION;

EID: 0033956595     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043764-200001000-00007     Document Type: Article

References (19)

1. Spits H, Blom B, Jaleco AC, et al. Early stages in the development of human T, natural killer and thymic dendritic cells. Immunol Rev. 1998;165:75-86.
2. Zamai L, Ahmad M, Bennett IM, Azzoni L, Alnemri ES, Perussia B. Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J Exp Med. 1988;188:2375-2380.
3. Tomasello E, Olcese L, Vely F, et al. Gene structure, expression pattern, and biological activity of mouse killer cell activating receptor-associated protein (KARAP/DAP-12). J Biol Chem. 1998; 273:3415-3419.
4. Raulet DH, Held W, Correa I, Dorfman JR, Wu MF, Corral L. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class-I-specific Ly49 receptors. Immunol Rev. 1997;155:41-52.
5. Pastanen R, Koskinen H, Hemmonintis K. TNFα in patients who have asbestosis and develop cancer. Medicine. 1995;52: 316-319.
6. Tsang PH, Chu FN, Fischbein A, Bekesi G. Impairments in functional subsets of T-suppressor (CD-8) lymphocytes, monocytes, and natural killer cells among asbestos-exposed workers. Clin Immunol Immunopathol. 1988;47:323-332.
7. Al-Jarad N, Macey M, Yhayakumar S, Newland AC, Rudd RM. Lymphocyte subsets in subjects exposed to asbestos: changes in circulating natural killer cells. Br J Ind Med. 1992;49:811-814.
8. Kubota M, Kagamimori S, Yokoyama K, Okada A. Reduced killer cell activity of lymphocytes from patients with asbestosis. Br J Ind Med. 1985;42:276-280.
9. deShazo RD, Morgan J, Bozelka B, Chapman Y. Natural killer cell activity in asbestos workers. Interactive effects of smoking and asbestos exposure. Chest. 1988;94:482-485.
10. Ginns LC, Ryu JH, Rogol PR, Sprince NL, Oliver LC, Larsson CJ. Natural killer cell activity in cigarette smokers and asbestos workers. Am Rev Respir Dis. 1985;131:831-834.
11. Yoneda T, Kitamunra H, Narita N, Mikami R, Yokoyama K. NK cell activity in asbestosis. Eur J Respir Dis. 1986;68: 64-67.
12. Kagamimori S, Watanabe M, Kubota M, Okada A, Yokoyama K, Nobutoma K. Serum interferon levels and natural killer cell activity in patients with asbestosis. Thorax. 1984;39:65-66.
13. Newman LS, Kreiss K, Cambell PA. Natural killer cell tumoricidal activity in cigarette smokers and in silicotics. Clin Immunol Immunopathol. 1991;60:399-411.
14. Tollerud DJ, Clark JW, Brown LM, et al. Association of cigarette smoking with decreased numbers of circulating natural killer cells. Am Rev Respir Dis. 1989; 139:194-198.
15. Tuch H, Tulchinsky TH, Casper M, Kaane H. Medical screening of former asbestos cement workers in Israel: a pilot program. Am J Ind Med. 1986;10:471-478.
16. Tulchinsky TH, Ginsberg GM, Iscovich J, Shihab S, Fischbein A, Richter ED. Cancer in ex-asbestos cement workers in Israel, 1953-1992. Am J Ind Med. 1999; 35:1-8.
17. Robinson BW. Asbestos and cancer: human natural killer cell activity is suppressed by asbestos fibers but can be restored by recombinant interleukin-2. Am Rev Respir Dis. 1989;139: 897-901.
18. Manning LS, Davis MR, Robinson BW. Asbestos fibers inhibit the in vitro activity of lymphokine-activated killer (LAK) cells from healthy individuals and patients with malignant mesothelioma. Clin Exp Immunol. 1991;83:85-91.
19. Moniewska A, Szgba K, Jazwiec B, Lange A. Chrysolite affects Yac-1 cytolytic activity of spleen cells. Arch Immunol Ther Exp Wansz. 1989;37:61-68.